A network pharmacology-based investigation of emodin against pancreatic adenocarcinoma

Pancreatic adenocarcinoma (PAAD) is one of the most common malignancies worldwide with an increasing incidence and poor outcome due to the lack of effective diagnostic and treatment methods. Emerging evidence implicates that emodin displays extensive spectrum anticancer properties. Differential expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xueying, Huang, Bingqian, Zhu, Jingyi, Yamaguchi, Takuji, Hu, Ailing, Tabuchi, Masahiro, Watanabe, Daisuke, Yoshikawa, Seiichiro, Mizushima, Shinobu, Mizushima, Akio, Xia, Shilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194452/
https://www.ncbi.nlm.nih.gov/pubmed/37335741
http://dx.doi.org/10.1097/MD.0000000000033521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194452/
https://www.ncbi.nlm.nih.gov/pubmed/37335741
http://dx.doi.org/10.1097/MD.0000000000033521

Ejemplares similares